These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12118862)

  • 1. Efficacy and toxicity of a protocol using sirolimus, tacrolimus and daclizumab in a nonhuman primate renal allotransplant model.
    Montgomery SP; Mog SR; Xu H; Tadaki DK; Hirshberg B; Berning JD; Leconte J; Harlan DM; Hale D; Kirk AD
    Am J Transplant; 2002 Apr; 2(4):381-5. PubMed ID: 12118862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.
    Woodroffe R; Yao GL; Meads C; Bayliss S; Ready A; Raftery J; Taylor RS
    Health Technol Assess; 2005 May; 9(21):1-179, iii-iv. PubMed ID: 15899149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of combined treatment with CD25- and CD154-specific monoclonal antibodies in non-human primate allotransplantation.
    Xu H; Elster EA; Blair PJ; Burkly LC; Tadaki DK; Harlan DM; Kirk AD
    Am J Transplant; 2003 Nov; 3(11):1350-4. PubMed ID: 14525594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppression With CD40 Costimulatory Blockade Plus Rapamycin for Simultaneous Islet-Kidney Transplantation in Nonhuman Primates.
    Oura T; Hotta K; Lei J; Markmann J; Rosales I; Dehnadi A; Kawai K; Ndishabandi D; Smith RN; Cosimi AB; Kawai T
    Am J Transplant; 2017 Mar; 17(3):646-656. PubMed ID: 27501203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation.
    Rostaing L; Cantarovich D; Mourad G; Budde K; Rigotti P; Mariat C; Margreiter R; Capdevilla L; Lang P; Vialtel P; Ortuño-Mirete J; Charpentier B; Legendre C; Sanchez-Plumed J; Oppenheimer F; Kessler M;
    Transplantation; 2005 Apr; 79(7):807-14. PubMed ID: 15818323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the immunosuppressive regime of Edmonton protocol on the long-term in vitro insulin secretion from islets of two different species and age categories.
    Hyder A; Laue C; Schrezenmeir J
    Toxicol In Vitro; 2005 Jun; 19(4):541-6. PubMed ID: 15826812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of immunosuppressive drugs on in vitro neogenesis of human islets: mycophenolate mofetil inhibits the proliferation of ductal cells.
    Gao R; Ustinov J; Korsgren O; Otonkoski T
    Am J Transplant; 2007 Apr; 7(4):1021-6. PubMed ID: 17391142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced exposure to calcineurin inhibitors in renal transplantation.
    Ekberg H; Tedesco-Silva H; Demirbas A; Vítko S; Nashan B; Gürkan A; Margreiter R; Hugo C; Grinyó JM; Frei U; Vanrenterghem Y; Daloze P; Halloran PF;
    N Engl J Med; 2007 Dec; 357(25):2562-75. PubMed ID: 18094377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of basiliximab and daclizumab with triple immunosuppression in renal transplantation.
    Aktas S; Colak T; Baskin E; Sevmis S; Ozdemir H; Moray G; Karakayali H; Haberal M
    Transplant Proc; 2011 Mar; 43(2):453-7. PubMed ID: 21440732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liver.
    Mingozzi F; Hasbrouck NC; Basner-Tschakarjan E; Edmonson SA; Hui DJ; Sabatino DE; Zhou S; Wright JF; Jiang H; Pierce GF; Arruda VR; High KA
    Blood; 2007 Oct; 110(7):2334-41. PubMed ID: 17609423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choice of immunosuppression influences cytomegalovirus DNAemia in cynomolgus monkey (Macaca fascicularis) islet allograft recipients.
    Han D; Berman DM; Willman M; Buchwald P; Rothen D; Kenyon NM; Kenyon NS
    Cell Transplant; 2010; 19(12):1547-61. PubMed ID: 20587138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation.
    Sarwal MM; Vidhun JR; Alexander SR; Satterwhite T; Millan M; Salvatierra O
    Transplantation; 2003 Nov; 76(9):1331-9. PubMed ID: 14627912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rabbit antithymocyte globulin induction and sirolimus monotherapy supports prolonged islet allograft function in a nonhuman primate islet transplantation model.
    Hirshberg B; Preston EH; Xu H; Tal MG; Neeman Z; Bunnell D; Soleimanpour S; Hale DA; Kirk AD; Harlan DM
    Transplantation; 2003 Jul; 76(1):55-60. PubMed ID: 12865786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized trial of three different immunosuppressive regimens to prevent chronic renal allograft rejection.
    Burke GW; Ciancio C; Blomberg BB; Rosen A; Suzart K; Roth D; Kupin W; Esquenazi V; Miller J
    Transplant Proc; 2002 Aug; 34(5):1610-1. PubMed ID: 12176505
    [No Abstract]   [Full Text] [Related]  

  • 15. Daclizumab induction, tacrolimus, mycophenolate mofetil and steroids as an immunosuppression regimen for primary kidney transplant recipients.
    Ciancio G; Burke GW; Suzart K; Roth D; Kupin W; Rosen A; Olson L; Esquenazi V; Miller J
    Transplantation; 2002 Apr; 73(7):1100-6. PubMed ID: 11965039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IDEC-131 (anti-CD154), sirolimus and donor-specific transfusion facilitate operational tolerance in non-human primates.
    Preston EH; Xu H; Dhanireddy KK; Pearl JP; Leopardi FV; Starost MF; Hale DA; Kirk AD
    Am J Transplant; 2005 May; 5(5):1032-41. PubMed ID: 15816883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid-withdrawal at 3 days after renal transplantation with anti-IL-2 receptor alpha therapy: a prospective, randomized, multicenter study.
    ter Meulen CG; van Riemsdijk I; Hené RJ; Christiaans MH; Borm GF; van Gelder T; Hilbrands LB; Weimar W; Hoitsma AJ
    Am J Transplant; 2004 May; 4(5):803-10. PubMed ID: 15084178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of immunosuppressive therapy after experimental small bowel transplantation in rats.
    Pech T; Fujishiro J; Finger T; von Websky M; Stoffels B; Wehner S; Abu-Elmagd K; Kalff JC; Schaefer N
    Transpl Immunol; 2011 Sep; 25(2-3):112-8. PubMed ID: 21820512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathological study of intrahepatic islets transplanted in the nonhuman primate model using edmonton protocol immunosuppression.
    Hirshberg B; Mog S; Patterson N; Leconte J; Harlan DM
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5424-9. PubMed ID: 12466330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of three tacrolimus-based immunosuppressive regimens in lung transplantation.
    Bhorade SM; Jordan A; Villanueva J; Yu A; Kramer H; Vigneswaran WT; Garrity ER
    Am J Transplant; 2003 Dec; 3(12):1570-5. PubMed ID: 14629288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.